GlassScriptPhysician profile
Zaher Fanari
NPI 1427384221
$26,470.58
in general payments reported to CMS, 2019-2025
31 companies · $1,348 in 2025
The $1,348 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,829 · 2020: $7,620 · 2021: $2,933 · 2022: $4,348 · 2023: $2,073 · 2024: $2,320 · 2025: $1,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,410 · Travel and Lodging: $1,332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,409.67 |
| Travel and Lodging | $1,331.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $9,606.49 | 2019-2020 | |
| Abbott Laboratories | $4,843.77 | 2019-2025 | Mitraclip, Amplatzer Talisman, Coroflow |
| Medtronic, INC. | $4,664.11 | 2021-2025 | Corevalve Evolut R, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $2,058.43 | 2019-2025 | General - Balloon Catheters, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $1,571.06 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $1,200.95 | 2019-2024 | Sapien 3 Ultra Resilia |
| Philips North America LLC | $684.52 | 2020-2024 | (Bs3) Intracardiac Und, (Ao0) Igt Devices Intracardiac, (P84) Igt Devices Systems |
| Shockwave Medical, INC | $661.83 | 2021-2025 | |
| Janssen Scientific Affairs, LLC | $152.06 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $139.65 | 2022-2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $106.67 | 2020-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.08 | 2021-2024 | Jardiance |
| Astellas Pharma US INC | $76.99 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $74.79 | 2019-2023 | Uptravi, Opsumit |
| Cardiva Medical, INC. | $72.20 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Savvywire |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $68.22 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.48 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $47.27 | 2020-2021 | |
| Amgen INC. | $39.98 | 2019 | |
| Cardinal Health 200 LLC | $36.41 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $31.65 | 2022 | |
| Novo Nordisk INC | $31.01 | 2024 | |
| Cook Medical LLC | $27.04 | 2019 | |
| Sanofi-Aventis U.S. LLC | $25.21 | 2019 | |
| Surmodics, INC. | $23.05 | 2023 | Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access Guide Sheath |
| Lexicon Pharmaceuticals, INC. | $21.53 | 2023 | Inpefa |
| Angiodynamics, INC. | $18.55 | 2023 | Alphavac |
| Regeneron Healthcare Solutions, INC. | $16.66 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.66 | 2019 | |
| Chiesi USA, INC. | $12.91 | 2023 | Kengreal |
| E.R. Squibb & Sons, L.L.C. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaher Fanari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.